Pharming Group
PHAR
4 hedge funds and large institutions have $369K invested in Pharming Group in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
60% more capital invested
Capital invested by funds: $230K → $369K (+$139K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$140K |
| 2 |
Morgan Stanley
New York
|
+$3.96K |
| 3 |
BlackRock
New York
|
+$2.58K |
| 4 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$87 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.59K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.74K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SBCM
1
Silverberg Bernstein Capital Management
Armonk,
New York
| $339K | +$140K | +17,675 | +75% |
|
|
2
Morgan Stanley
New York
| $27.2K | +$3.96K | +500 | +18% |
|
|
3
BlackRock
New York
| $2.69K | +$2.58K | +326 | New |
|
|
FFA
4
Farther Finance Advisors
San Francisco,
California
| $91 | +$87 | +11 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$6.59K | -789 | Closed |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| – | -$4.74K | -568 | Closed |
|
PHAR Hedge Fund Activity: Q3 2024 in Review
4 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q3 2024, worth a combined $369K — up 60% from $230K a quarter earlier.
Fund positioning in PHAR was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Silverberg Bernstein Capital Management, adding an estimated $140K. The largest seller was UBS Group, exiting entirely with an estimated $6.59K sold.
- 4 institutional investors held Pharming Group (PHAR) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $369K of Pharming Group stock for Q3 2024, up 60% quarter-over-quarter.
- 2 funds opened new Pharming Group positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest Pharming Group buyer in Q3 2024 was Silverberg Bernstein Capital Management, an estimated $140K added.
- The largest Pharming Group seller in Q3 2024 was UBS Group, an estimated $6.59K sold.
Based on aggregated 13F filings for Q3 2024.